Corazon Pharma Private Limited, a active private limited company, was established on 29 September 2009 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH2009PTC196106. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Formerly known as Vamacell Biotech Private Limited. It upholds a compliant status. Its leadership includes Pradip Chandrakant Mehta (Director), Riyaz Shamsuddin Khan (Director), Dilip Iswarlal Parekh (Director). Past directors included Zakaul Inam Shahzad, Pradnaya Satish Vyawhare, Satish Shashikar Vyawhare. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 614 , Midas Sahar Plaza, J B Nagar, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra, 400059.
U24100MH2009PTC196106
196106
29 September 2009
₹1.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Corazon Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pradip Chandrakant Mehta | Director | 20 Dec 2011 | Current |
| Riyaz Shamsuddin Khan | Director | 19 Mar 2014 | Current |
| Dilip Iswarlal Parekh | Director | 20 Dec 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Mar 2014 | Past |
| Pramod Abcsdd | Director | 05 Jan 2012 | Past |
| Pramod Abcsdd | Director | 05 Jan 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Corazon Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 10.82% decrease. The company also saw a substantial fall in profitability, with a 78.19% decrease in profit. The company's net worth moved up by a moderate rise of 6.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Corazon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Corazon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Corazon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corazon Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Corazon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Corazon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Riyaz Shamsuddin Khan was appointed as a Director was appointed as a Director on 19 Mar 2014 & has been associated with this company since 11 years 8 months . was recorded as a recent event.
Pradip Chandrakant Mehta was appointed as a Director was appointed as a Director on 20 Dec 2011 & has been associated with this company since 13 years 11 months . was recorded as a recent event.
Dilip Iswarlal Parekh was appointed as a Director was appointed as a Director on 20 Dec 2011 & has been associated with this company since 13 years 11 months . was recorded as a recent event.
Corazon Pharma Private Limited was registered on 29 Sep 2009 with Roc Mumbai & aged 16 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Corazon Pharma Private Limited is U24100MH2009PTC196106.
Corazon Pharma Private Limited is headquartered at 614 , Midas Sahar Plaza, J B Nagar, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra, 400059.
Corazon Pharma Private Limited was incorporated on 29 September 2009.
The current directors of Corazon Pharma Private Limited are
The primary industry of Corazon Pharma Private Limited is Trade.
Corazon Pharma Private Limited is unlisted.
The authorized capital of Corazon Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Corazon Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX